These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 456975)

  • 41. [PATHOPHYSIOLOGY AND CLINICAL ASPECTS OF SECONDARY ALDOSTERONISM AND ITS TREATMENT].
    HOFFMEISTER W
    Folia Clin Int (Barc); 1964 Mar; 14():124-44. PubMed ID: 14153959
    [No Abstract]   [Full Text] [Related]  

  • 42. Diagnostic usefulness of the random urine Na/K ratio in predicting therapeutic response for diuretics in cirrhotic patients with ascites.
    Mohii el SM; El Mansy IM; Salah M; Khedr MA
    J Egypt Soc Parasitol; 2013 Dec; 43(3):767-76. PubMed ID: 24640876
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Choice of diuretics in cirrhosis with ascites.
    Qureshi H; Shahid A; Zuberi SJ; Hassan R; Alam E
    J Pak Med Assoc; 1987 Jun; 37(6):142-5. PubMed ID: 3114508
    [No Abstract]   [Full Text] [Related]  

  • 44. Temporal relationship between hyperaldosteronism, sodium retention and ascites formation in rats with experimental cirrhosis.
    Jiménez W; Martinez-Pardo A; Arroyo V; Bruix J; Rimola A; Gaya J; Rivera F; Rodés J
    Hepatology; 1985; 5(2):245-50. PubMed ID: 3979957
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Spot urinary sodium for assessing dietary sodium restriction in cirrhotic ascites.
    El-Bokl MA; Senousy BE; El-Karmouty KZ; Mohammed Iel K; Mohammed SM; Shabana SS; Shalaby H
    World J Gastroenterol; 2009 Aug; 15(29):3631-5. PubMed ID: 19653340
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Changes in urinary aldosterone and the role of hyperaldosteronism in the hydropigenous syndrome of cirrhotics].
    MALLEIN R; BESSET C; OLIVIER L; VACHON A
    Lyon Med; 1961 May; 93():1045-53. PubMed ID: 13765851
    [No Abstract]   [Full Text] [Related]  

  • 47. Can 24-h urine sodium excretion be replaced by spot urine sodium/potassium in patients with decompensated cirrhosis?
    Cholongitas E; Karatapanis S; Nakouti T; Birtsou C; Skorda L; Kouvelis I; Papastergiou V; Papachrysos N; Goulis J; Akriviadis E
    Liver Int; 2012 Jan; 32(1):172-3. PubMed ID: 22098704
    [No Abstract]   [Full Text] [Related]  

  • 48. [State of the renin-angiotensin system in thyrotoxicosis].
    Koev D
    Probl Endokrinol (Mosk); 1975; 21(3):16-21. PubMed ID: 49892
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [ALTERATIONS IN THE EXCRETION OF ALDOSTERONE AND ELECTROLYTES IN HEPATIC CIRRHOSIS, CONGESTIVE HEART FAILURE AND IDIOPATHIC EDEMAS].
    ARGUEELLES AE; CHEKHERDEMIAN M; MUNIAGURRIA JL; RICCA A
    Rev Asoc Med Argent; 1964 May; 78():236-40. PubMed ID: 14159725
    [No Abstract]   [Full Text] [Related]  

  • 50. [Diagnosis of secondary hyperaldosteronism].
    Werning C; Siegenthaler W
    Dtsch Med Wochenschr; 1969 Oct; 94(40):2049-51. PubMed ID: 4311366
    [No Abstract]   [Full Text] [Related]  

  • 51. Raised plasma angiotensin II and aldosterone during dietary sodium restriction in man.
    Brown JJ; Lever AF; Morton JJ; Fraser R; Love DR; Robertson JI
    Lancet; 1972 Nov; 2(7787):1106-7. PubMed ID: 4117201
    [No Abstract]   [Full Text] [Related]  

  • 52. Effects of adding hypertonic saline solutions and/or etilefrine to standard diuretics therapy in cirrhotic patients with ascites.
    Radwan H; Ibrahim O; Badra G; El-Said H; El-Haggar S
    Eur Rev Med Pharmacol Sci; 2022 Sep; 26(18):6608-6619. PubMed ID: 36196711
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hyperaldosteronism associated with liver metastases.
    Pandya KJ; Whitehead R; Crowley J; Citrin DL
    JAMA; 1980 Jul; 244(2):171-2. PubMed ID: 7382077
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [MEASUREMENT OF ALDOSTERONE SECRETION DURING THE ADMINISTRATION OF A SEMI-SYNTHETIC ADRENOSTATIC AGENT, HEPARINOID RO I-8307].
    VEYRAT R; MANNING EL; FABRE J; MULLER AF
    Rev Fr Etud Clin Biol; 1963; 8():667-73. PubMed ID: 14082398
    [No Abstract]   [Full Text] [Related]  

  • 55. A simple method for definition of incomplete suppression of aldosterone and its association with hypertension and hypokalaemia in man.
    Adam WR
    Clin Sci (Lond); 1986 Oct; 71(4):375-83. PubMed ID: 3757436
    [TBL] [Abstract][Full Text] [Related]  

  • 56. EXPERIMENTAL ASCITES. VI. THE EFFECTS OF HEPATIC VENOUS OUTFLOW OBSTRUCTION AND ASCITES ON ALDOSTERONE SECRETION.
    ORLOFF MJ; ROSS TH; BADDELEY RM; NUTTING RO; SPITZ BR; SLOOP RD; NEESBY T; HALASZ NA
    Surgery; 1964 Jul; 56():83-98. PubMed ID: 14174755
    [No Abstract]   [Full Text] [Related]  

  • 57. [CONSIDERATIONS ON THE TREATMENT OF SECONDARY HYPERALDOSTERONISM].
    ANDREUKERN F; HOYUELAJIMENEZ M; CARNEADODELAFUENTE J
    Rev Iber Endocrinol; 1964; 11():117-29. PubMed ID: 14161805
    [No Abstract]   [Full Text] [Related]  

  • 58. Sodium and fluid retention in hepatic cirrhosis: a role for circulating hormones?
    Sewell RB; Poston L; Wilkinson SP
    Aust N Z J Med; 1984 Jun; 14(3):297-304. PubMed ID: 6594125
    [No Abstract]   [Full Text] [Related]  

  • 59. Urinary free aldosterone in healthy people and in patients with primary aldosteronism.
    Deck KA; Champion PK; Conn JW
    J Clin Endocrinol Metab; 1973 Apr; 36(4):756-60. PubMed ID: 4686382
    [No Abstract]   [Full Text] [Related]  

  • 60. Chloride, potassium, and aldosterone excretion in a sodium-retaining patient (hepatic cirrhosis) during forced natriuresis.
    WESSON LG; SUNSHINE A; EPSTEIN JA
    J Lab Clin Med; 1958 Jul; 52(1):78-82. PubMed ID: 13549852
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.